Michael Werner, Founder of the Alliance for Regenerative Medicine, presented at last year's Stem Cells USA & Regenerative Medicine Congress on the topic, âARM update: regulatory issues affecting commercialization.'
In his presentation, Michael gives an overview on:
- Cell potency assay standards
- Use of appropriate animal models
- Improved communication between sponsors and the FDA
- Patient involvement in the approval process
For up to date information on the stem cells and regenerative medicine market, register now for Stem Cells USA & Regenerative Medicine Congress.